Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by F. Perrone
The diagnostic puzzle: Meigs' syndrome, pseudo‐Meigs' syndrome and ovarian cancer
An 87-year-old woman presenting to Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, with abdominal pain, weight loss, ascites, pleural effusion and an elevated CA 125 level (1365 U/mL) was suspected to have advanced ovarian cancer. Transvaginal ultrasound examination revealed a large solid adnexal mass (102 × 81 × 137 mm) with hyperechogenic tissue, cystic areas and acoustic shadowing (Figure 1a), and moderate vascularization on Color Doppler (Figure 2a).
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
Publication HistoryPublished online: May 04, 2018Accepted: April 5, 2018; Received in revised form: December 7, 2017; Received: October 23, 2017;
health economicsThe effect of financial difficulties on clinical outcomes in Italian cancer patients: A pooled analysis of 16 academic prospective clinical trials
Background: Cancer may cause financial difficulties, particularly when co-payment is required for antineoplastic treatment. The impact of financial difficulties in countries with public health systems is unknown. We investigated the prognostic value of financial difficulties on clinical outcomes of cancer patients enrolled in academic clinical trials performed within the Italian public health system.
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
? † The views expressed in this article are the personal views of the author and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties. Background Cancer may cause financial difficulties, but its impact in countries with public health systems is unknown.
Toward the molecular dissection of peritoneal pseudomyxoma
Results KRAS and GNAS mutations were found in 72% and 52%, and their allelic frequency was below 10% in 55% and 43% of samples, respectively. KRAS and GNAS mutations were associated with worse progression-free survival (PFS) at univariate analysis (P = 0.006 and 0.011, respectively).
Towards the molecular dissection of peritoneal pseudomyxoma
Results KRAS and GNAS mutations were found in 72% and 52%, and their allelic frequency was below 10% in 55% and 43% of samples, respectively. KRAS and GNAS mutations were associated with worse progression-free survival (PFS) at univariate analysis (p=0.006 and p=0.011, respectively).
Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials
In this issue of Annals of Oncology, Fujiwara and co-workers present the detailed results of health-related quality of life (QoL) of the randomized, placebo-controlled trial testing the addition of the anti-angiopoietin agent trebananib to weekly paclitaxel in patients with recurrent epithelial ovarian cancer.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with F.
Contact F., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack